FibroBiologics Inc [FBLG] stock is trading at $0.34, up 32.27%. An important factor to consider is whether the stock is rising or falling in short-term value. The FBLG shares have gain 42.17% over the last week, with a monthly amount glided 30.41%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
FibroBiologics Inc [NASDAQ: FBLG] stock has seen the most recent analyst activity on December 12, 2024, when Rodman & Renshaw initiated its Buy rating and assigned the stock a price target of $12. Previously, H.C. Wainwright started tracking the stock with Buy rating on October 30, 2024, and set its price target to $12. On September 24, 2024, Maxim Group initiated with a Buy rating and assigned a price target of $12 on the stock.
FibroBiologics Inc [FBLG] stock has fluctuated between $0.22 and $2.34 over the past year. Currently, Wall Street analysts expect the stock to reach $9 within the next 12 months. FibroBiologics Inc [NASDAQ: FBLG] shares were valued at $0.34 at the most recent close of the market. An investor can expect a potential return of 2547.06% based on the average FBLG price forecast.
Analyzing the FBLG fundamentals
Gross Profit Margin for this corporation currently stands at 0.13% with Operating Profit Margin at -29.03%, Pretax Profit Margin comes in at -23.87%, and Net Profit Margin reading is -23.87%. To continue investigating profitability, this company’s Return on Assets is posted at -0.95, Equity is -6.09 and Total Capital is -5.47. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of12.53.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.2832 points at the first support level, and at 0.2225 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.3848, and for the 2nd resistance point, it is at 0.4257.
Ratios To Look Out For
For context, FibroBiologics Inc’s Current Ratio is 0.78. On the other hand, the Quick Ratio is 0.78, and the Cash Ratio is 0.81.
Transactions by insiders
Recent insider trading involved GARCIA RUBEN A, General Counsel, that happened on Dec 11 ’25 when 0.14 million shares were purchased. Chief Scientific Officer, Khoja Hamid completed a deal on May 27 ’25 to buy 20000.0 shares.
